Fuss Brands Corp. financial data

Symbol
FBDS on OTC
Location
80 Broad Street, 5 Th Floor, New York, NY
State of incorporation
NV
Fiscal year end
October 31
Former names
China Botanic Pharmaceutical (to 6/14/2022), RENHUANG PHARMACEUTICALS INC (to 10/27/2010), ANZA CAPITAL INC (to 8/15/2006), E-NET FINANCIAL COM CORP (to 5/21/2002), E-NET COM CORP (to 3/10/2000), E NET FINANCIAL CORP (to 1/26/2000), E NET CORP/NV (to 9/15/1999), E NET CORP (to 3/5/1999), COMTECH CONSOLIDATION GROUP INC (to 1/4/1999), SUARRO COMMUNICATIONS INC (to 6/23/1997), SOLUTIONS INC (to 1/16/1997)
Latest financial report
10-Q - Q4 2024 - Mar 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity -132 % +0.39%
Return On Equity 409 % +205%
Return On Assets -1.27K % -210%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.1M shares 0%
Common Stock, Shares, Outstanding 19.1M shares 0%
Entity Public Float 0 USD -100%
Common Stock, Value, Issued 19.1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 19.1M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 19.1M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 2.78M USD +479%
Operating Income (Loss) -2.78M USD -479%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.78M USD -476%
Net Income (Loss) Attributable to Parent -2.78M USD -476%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.15K USD -5.4%
Assets, Current 151K USD
Assets 232K USD +41.6%
Accounts Payable, Current 10.6K USD -60.1%
Accrued Liabilities, Current 162K USD +2.7%
Liabilities, Current 994K USD +50.9%
Liabilities 994K USD +50.9%
Retained Earnings (Accumulated Deficit) -15.5M USD -21.9%
Stockholders' Equity Attributable to Parent -762K USD -54%
Liabilities and Equity 232K USD +41.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -77K USD +49.7%
Net Cash Provided by (Used in) Financing Activities 80.7K USD -45.8%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 19.1M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.15K USD -5.4%
Preferred Stock, Shares Issued 824K shares
Preferred Stock, Shares Authorized 2.5M shares
Additional Paid in Capital 14.8M USD +20.5%
Preferred Stock, Shares Outstanding 824K shares
Interest Expense 5.07K USD +2.08%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares